Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

On Monday, Black Diamond Therapeutics Inc (BDTX) stock saw a modest uptick, ending the day at $4.35 which represents a slight increase of $0.12 or 2.84% from the prior close of $4.23. The stock opened ...

Robert Burns, an analyst from H.C. Wainwright, reiterated the Buy rating on Black Diamond Therapeutics (BDTX – Research Report). The ...

Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 23.80% ...

Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...

Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment ...

In an age when you can get just about anything online, it's probably no surprise that you can buy a diamond-making machine for $200,000 on Chinese eCommerce site Alibaba. If, like me, you haven't ...

Learn more. Please also consider subscribing to WIRED In an age when you can get just about anything online, it's probably no surprise that you can buy a diamond-making machine for $200,000 on ...

It's officially October, which means Black Friday deals are near. The second Amazon Prime Day sale, slated for October 8 and 9, kicks off the 2024 Black Friday shipping season. That means we ...